ZELIS HEALTHCARE CORPORATION
SHATTERPROOF
BIOTECHNOLOGY INNOVATION ORGANIZATION
ML
Background
Career
AG
WASHINGTON, DC · current
Government experience
Leg. Asst.
Sen. Hoeven (2025-2026); Leg. Aide, Sen. Hoeven (2025); Leg. Cor., Sen. Hoeven (2023-2024); Staff Asst., Sen. Hoeven (2022-2023); Intern, Sen. KCramer (2020).
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
3
past 12 months
Filings
3
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATECenters For Medicare and Medicaid Services (CMS)
Specific issues
Issues related to transparency in healthcare coverage, including H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Issues related to Substance Use Disorder programs; Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44) funding; Issues related to H.R. 2509/S. 931 - COMPLETE Care Act; Issues related to behavioral health; Issues related to the Substance Abuse and Mental Health Services Administration's mental health and addiction treatment locator, FindTreatment.gov, and including quality indicators for addiction treatment.
Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262 / S. 3302 - Mikaela Naylon Give Kids a Chance Act of 2025; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75), including the extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases; Issues related to the biotech ecosystem, including most-favored-nation drug pricing; Issues related to PBM reform, PAHPA reauthorization; and PDUFA reauthorization.
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗